Bioluminescence inhibition assay for the detection of hydroxylated polychlorinated biphenyls

Krystal Teasley Hamorsky, C. Mark Ensor, Emre Dikici, Patrizia Pasini, Leonidas G Bachas, Sylvia Daunert

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Hydroxylated polychlorinated biphenyls (OH-PCBs) are an important class of contaminants that mainly originate from polychlorinated biphenyl metabolism. They may conceivably be as dangerous and persistent as the parent compounds; most prominently, OH-PCBs are endocrine disruptors. Due to increasing evidence of the presence of OH-PCBs in the environment and in living organisms, including humans, and of their toxicity, methods of detection for OH-PCBs are needed in the environmental and medical fields. Herein, we describe the development and optimization of a protein-based inhibition assay for the quantification of OH-PCBs. Specifically, the photoprotein aequorin was utilized for the detection of OH-PCBs. We hypothesized that OH-PCBs interact with aequorin, and we established that OH-PCBs actually inhibit the bioluminescence of aequorin in a dose-dependent manner. We took advantage of this phenomenon to develop an assay that is capable of detecting a wide variety of OH-PCBs with a range of detection limits, the best detection limit being 11 nM for the compound 2-hydroxy-2′,3,4′,5′,6-pentachorobiphenyl. The viability of this system for the screening of OH-PCBs in spiked biological and environmental samples was also established. We envision the implementation of this novel bioluminescence inhibition assay as a rapid, sensitive, and cost-effective method for monitoring OH-PCBs. Furthermore, to the best of our knowledge, this is the first time aequorin has been employed to detect an analyte by the inhibition of its bioluminescence reaction. Hence, this strategy may prove to be a general approach for the development of a new generation of protein-based inhibition assays.

Original languageEnglish
Pages (from-to)7648-7655
Number of pages8
JournalAnalytical Chemistry
Volume84
Issue number18
DOIs
StatePublished - Sep 18 2012

Fingerprint

Bioluminescence
Polychlorinated Biphenyls
Assays
Aequorin
hydroxide ion
Luminescent Proteins
Endocrine Disruptors
Metabolism

ASJC Scopus subject areas

  • Analytical Chemistry

Cite this

Bioluminescence inhibition assay for the detection of hydroxylated polychlorinated biphenyls. / Teasley Hamorsky, Krystal; Ensor, C. Mark; Dikici, Emre; Pasini, Patrizia; Bachas, Leonidas G; Daunert, Sylvia.

In: Analytical Chemistry, Vol. 84, No. 18, 18.09.2012, p. 7648-7655.

Research output: Contribution to journalArticle

Teasley Hamorsky, Krystal ; Ensor, C. Mark ; Dikici, Emre ; Pasini, Patrizia ; Bachas, Leonidas G ; Daunert, Sylvia. / Bioluminescence inhibition assay for the detection of hydroxylated polychlorinated biphenyls. In: Analytical Chemistry. 2012 ; Vol. 84, No. 18. pp. 7648-7655.
@article{4ea56b55192e470e9b7bfd2486f54b47,
title = "Bioluminescence inhibition assay for the detection of hydroxylated polychlorinated biphenyls",
abstract = "Hydroxylated polychlorinated biphenyls (OH-PCBs) are an important class of contaminants that mainly originate from polychlorinated biphenyl metabolism. They may conceivably be as dangerous and persistent as the parent compounds; most prominently, OH-PCBs are endocrine disruptors. Due to increasing evidence of the presence of OH-PCBs in the environment and in living organisms, including humans, and of their toxicity, methods of detection for OH-PCBs are needed in the environmental and medical fields. Herein, we describe the development and optimization of a protein-based inhibition assay for the quantification of OH-PCBs. Specifically, the photoprotein aequorin was utilized for the detection of OH-PCBs. We hypothesized that OH-PCBs interact with aequorin, and we established that OH-PCBs actually inhibit the bioluminescence of aequorin in a dose-dependent manner. We took advantage of this phenomenon to develop an assay that is capable of detecting a wide variety of OH-PCBs with a range of detection limits, the best detection limit being 11 nM for the compound 2-hydroxy-2′,3,4′,5′,6-pentachorobiphenyl. The viability of this system for the screening of OH-PCBs in spiked biological and environmental samples was also established. We envision the implementation of this novel bioluminescence inhibition assay as a rapid, sensitive, and cost-effective method for monitoring OH-PCBs. Furthermore, to the best of our knowledge, this is the first time aequorin has been employed to detect an analyte by the inhibition of its bioluminescence reaction. Hence, this strategy may prove to be a general approach for the development of a new generation of protein-based inhibition assays.",
author = "{Teasley Hamorsky}, Krystal and Ensor, {C. Mark} and Emre Dikici and Patrizia Pasini and Bachas, {Leonidas G} and Sylvia Daunert",
year = "2012",
month = "9",
day = "18",
doi = "10.1021/ac301872u",
language = "English",
volume = "84",
pages = "7648--7655",
journal = "Analytical Chemistry",
issn = "0003-2700",
publisher = "American Chemical Society",
number = "18",

}

TY - JOUR

T1 - Bioluminescence inhibition assay for the detection of hydroxylated polychlorinated biphenyls

AU - Teasley Hamorsky, Krystal

AU - Ensor, C. Mark

AU - Dikici, Emre

AU - Pasini, Patrizia

AU - Bachas, Leonidas G

AU - Daunert, Sylvia

PY - 2012/9/18

Y1 - 2012/9/18

N2 - Hydroxylated polychlorinated biphenyls (OH-PCBs) are an important class of contaminants that mainly originate from polychlorinated biphenyl metabolism. They may conceivably be as dangerous and persistent as the parent compounds; most prominently, OH-PCBs are endocrine disruptors. Due to increasing evidence of the presence of OH-PCBs in the environment and in living organisms, including humans, and of their toxicity, methods of detection for OH-PCBs are needed in the environmental and medical fields. Herein, we describe the development and optimization of a protein-based inhibition assay for the quantification of OH-PCBs. Specifically, the photoprotein aequorin was utilized for the detection of OH-PCBs. We hypothesized that OH-PCBs interact with aequorin, and we established that OH-PCBs actually inhibit the bioluminescence of aequorin in a dose-dependent manner. We took advantage of this phenomenon to develop an assay that is capable of detecting a wide variety of OH-PCBs with a range of detection limits, the best detection limit being 11 nM for the compound 2-hydroxy-2′,3,4′,5′,6-pentachorobiphenyl. The viability of this system for the screening of OH-PCBs in spiked biological and environmental samples was also established. We envision the implementation of this novel bioluminescence inhibition assay as a rapid, sensitive, and cost-effective method for monitoring OH-PCBs. Furthermore, to the best of our knowledge, this is the first time aequorin has been employed to detect an analyte by the inhibition of its bioluminescence reaction. Hence, this strategy may prove to be a general approach for the development of a new generation of protein-based inhibition assays.

AB - Hydroxylated polychlorinated biphenyls (OH-PCBs) are an important class of contaminants that mainly originate from polychlorinated biphenyl metabolism. They may conceivably be as dangerous and persistent as the parent compounds; most prominently, OH-PCBs are endocrine disruptors. Due to increasing evidence of the presence of OH-PCBs in the environment and in living organisms, including humans, and of their toxicity, methods of detection for OH-PCBs are needed in the environmental and medical fields. Herein, we describe the development and optimization of a protein-based inhibition assay for the quantification of OH-PCBs. Specifically, the photoprotein aequorin was utilized for the detection of OH-PCBs. We hypothesized that OH-PCBs interact with aequorin, and we established that OH-PCBs actually inhibit the bioluminescence of aequorin in a dose-dependent manner. We took advantage of this phenomenon to develop an assay that is capable of detecting a wide variety of OH-PCBs with a range of detection limits, the best detection limit being 11 nM for the compound 2-hydroxy-2′,3,4′,5′,6-pentachorobiphenyl. The viability of this system for the screening of OH-PCBs in spiked biological and environmental samples was also established. We envision the implementation of this novel bioluminescence inhibition assay as a rapid, sensitive, and cost-effective method for monitoring OH-PCBs. Furthermore, to the best of our knowledge, this is the first time aequorin has been employed to detect an analyte by the inhibition of its bioluminescence reaction. Hence, this strategy may prove to be a general approach for the development of a new generation of protein-based inhibition assays.

UR - http://www.scopus.com/inward/record.url?scp=84866424048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866424048&partnerID=8YFLogxK

U2 - 10.1021/ac301872u

DO - 10.1021/ac301872u

M3 - Article

C2 - 22908962

AN - SCOPUS:84866424048

VL - 84

SP - 7648

EP - 7655

JO - Analytical Chemistry

JF - Analytical Chemistry

SN - 0003-2700

IS - 18

ER -